Drug Information

Drug General Information
Drug ID
D0C5FQ
Former ID
DNCL003306
Drug Name
BHT-3009
Drug Type
Vaccine
Indication Multiple scierosis [ICD9: 340; ICD10:G35] Phase 2 [521894]
Company
Bayhill Therapeutics
Target and Pathway
Target(s) Myelin basic protein Target Info [530290]
WikiPathways MAPK Cascade
Structural Pathway of Interleukin 1 (IL-1)
Spinal Cord Injury
Glial Cell Differentiation
Neural Crest Differentiation
References
Ref 521894ClinicalTrials.gov (NCT00382629) BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis. U.S. National Institutes of Health.
Ref 530290BHT-3009, a myelin basic protein-encoding plasmid for the treatment of multiple sclerosis. Curr Opin Mol Ther. 2009 Aug;11(4):463-70.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.